Cargando…
Current Controversies in Newer Therapies to Treat Birth Asphyxia
Despite major advances in monitoring technology and knowledge of fetal and neonatal pathophysiology, neonatal hypoxic-ischemic encephalopathy (HIE) remains one of the main causes of severe adverse neurological outcome in children. Until recently, there were no therapies other than supportive measure...
Autor principal: | Wintermark, Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228371/ https://www.ncbi.nlm.nih.gov/pubmed/22164181 http://dx.doi.org/10.1155/2011/848413 |
Ejemplares similares
-
Myelination may be impaired in neonates following birth asphyxia
por: Olivieri, Bianca, et al.
Publicado: (2021) -
Magnesium for neuroprotection in birth asphyxia
por: Gathwala, Geeta, et al.
Publicado: (2010) -
“Risk factors of birth asphyxia”
por: Aslam, Hafiz Muhammad, et al.
Publicado: (2014) -
On Asphyxia Neonatorum and Infantile Mortality at Birth
por: Hamilton, G.
Publicado: (1855) -
Newer therapies for multiple sclerosis
por: Coles, Alasdair
Publicado: (2015)